Aspirin and P2Y12 inhibitors in treating COVID-19

被引：2
|
作者：
Khalaji, Amirmohammad [1 ]
Behnoush, Amir Hossein [1 ]
Peiman, Soheil [2 ,3 ]
机构：
[1] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[2] AdventHlth Orlando Hosp, Dept Internal Med, Orlando, FL USA
[3] AdventHlth Orlando Hosp, Dept Internal Med, 601 E Rollins St Suite 400, Orlando, FL 32803 USA
来源：
EUROPEAN JOURNAL OF INTERNAL MEDICINE | 2023年 / 110卷
关键词：
COVID-19; Aspirin; P2Y12; inhibitors; Platelet aggregation inhibitors; Meta-analysis;
D O I：
10.1016/j.ejim.2022.11.027
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 103
页数：3
相关论文
共 50 条
  • [31] Comparison of P2Y12 inhibitors and aspirin in secondary prevention of coronary events: a meta-analysis of RCTs
    Wang, Zhitao
    Zhu, Shanshan
    Zhu, Jiajia
    Jiang, Zhengli
    Ren, Yu
    BMC CARDIOVASCULAR DISORDERS, 2025, 25 (01):
  • [32] Assessment of P2Y12 inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
    Varenhorst, Christoph
    James, Stefan
    Erlinge, David
    Braun, Oscar O.
    Brandt, John T.
    Winters, Kenneth J.
    Jakubowski, Joseph A.
    Olofsson, Sylvia
    Wallentin, Lars
    Slegbahn, Agneta
    AMERICAN HEART JOURNAL, 2009, 157 (03) : 562.e1 - 562.e9
  • [33] P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
    Gragnano, Felice
    Cao, Davide
    Pirondini, Leah
    Franzone, Anna
    Kim, Hyo-Soo
    von Scheidt, Moritz
    Pettersen, Alf-Age R.
    Zhao, Qiang
    Woodward, Mark
    Chiarito, Mauro
    McFadden, Eugene P.
    Park, Kyung Woo
    Kastrati, Adnan
    Seljeflot, Ingebjorg
    Zhu, Yunpeng
    Windecker, Stephan
    Kang, Jeehoon
    Schunkert, Heribert
    Arnesen, Harald
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    Calabro, Paolo
    Pocock, Stuart
    Mehran, Roxana
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (02) : 89 - 105
  • [34] Short DAPT after DES: P2Y12 monotherapy is in, aspirin is out!
    Grines, Cindy L.
    Marshall, J. Jeffrey
    EUROPEAN HEART JOURNAL, 2019, 40 (31) : 2605 - 2606
  • [35] What is the best dose of aspirin in association with P2Y12 antagonists? reply
    Warner, Timothy D.
    HEART, 2011, 97 (03) : 264 - 264
  • [36] Antiplatelet Therapy n ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors
    Ristorto, Jessica
    Messas, Nathan
    Marchandot, Benjamin
    Kibler, Marion
    Hess, Sebastien
    Meyer, Nicolas
    Schaeffer, Michael
    Tuzin, Nicolas
    Ohlmann, Patrick
    Jesel, Laurence
    Morel, Olivier
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 674 - 689
  • [37] Response Variability to P2Y12 Receptor Inhibitors Expectations and Reality
    Siller-Matula, Jolanta M.
    Trenk, Dietmar
    Schroer, Karsten
    Gawaz, Meinrad
    Kristensen, Steen D.
    Storey, Robert F.
    Huber, Kurt
    JACC-CARDIOVASCULAR INTERVENTIONS, 2013, 6 (11) : 1111 - 1128
  • [38] Answer Regarding: Potent P2Y12 Inhibitors and Bleeding Complications
    Akinci, Sinan
    Coner, Ali
    Akbay, Ertan
    Adar, Adem
    Muderrisoglu, Haldun
    TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2022, 50 (07): : 545 - 546
  • [39] P2Y12 inhibitors in neuroendovascular surgery: An opportunity for precision medicine
    Rosengart, Axel
    Collins, Malie K.
    Hendrix, Philipp
    Uber, Ryley
    Sartori, Melissa
    Jain, Abhi
    Mao, Jennifer
    Goren, Oded
    Schirmer, Clemens M.
    Griessenauer, Christoph J.
    INTERVENTIONAL NEURORADIOLOGY, 2021, 27 (05) : 682 - 694
  • [40] Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors
    Winter, Max-Paul
    Grove, Erik L.
    De Caterina, Raffaele
    Gorog, Diana A.
    Ahrens, Ingo
    Geisler, Tobias
    Gurbel, Paul A.
    Tantry, Udaya
    Navarese, Eliano P.
    Siller-Matula, Jolanta M.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2017, 3 (04) : 221 - 234
12345